Annotation Detail for VKORC1
Basic Information Top
Gene Symbol: | VKORC1 ( EDTP308,FLJ00289,IMAGE3455200,MGC2694,MST134,MST576,VKCFD2,VKOR ) |
---|---|
Gene Full Name: | vitamin K epoxide reductase complex, subunit 1 |
Band: | 16p11.2 |
Quick Links | Entrez ID:79001; OMIM: 608547; Uniprot ID:VKOR1_HUMAN; ENSEMBL ID: ENSG00000167397; HGNC ID: 23663 |
Relate to Another Database: | SFARIGene; denovo-db |
No data |
No data |
Pathway ID | Pathway Name |
---|---|
Metabolism of proteins |
No data |
No data |
Pathway ID | Pathway Name |
---|---|
500540 | Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
No data |
Desease ID | Desease Name |
---|---|
1724 | Vascular disease |
1918 | Atherosclerosis |
2120 | Rabies |
Desease Name |
---|
HEMATOLOGICAL |
Thrombosis |
Atherosclerosis |
CARDIOVASCULAR |
warfarin response |
aortic dissection atherosclerosis, coronary stroke |
Coronary Disease |
PHARMACOGENOMIC |
warfarin sensitivity |
over anticoagulation |
METABOLIC |
anticoagulant complications |
warfarin therapy, response to |
phenprocoumon requirements |
warfarin maintenance dose |
Postoperative Complications |
Desease Name |
---|
Warfarin maintenance dose |
Desease Name |
---|
Warfarin resistance |
Vitamin K-dependent clotting factors, combined deficiency of, 2 |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of VKORC1 mRNA | affects expression | 21346803 |
C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of VKORC1 mRNA | affects expression | 21346803 |
C472791 | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of VKORC1 mRNA | increases expression | 16788091 |
C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane results in decreased expression of VKORC1 mRNA | decreases expression | 18648102 |
D000074 | Acenocoumarol | VKORC1 gene polymorphism affects the susceptibility to Acenocoumarol | affects response to substance | 16611310 19578179 18698879 |
D000074 | Acenocoumarol | VKORC1 intron SNP affects the susceptibility to Acenocoumarol | affects response to substance | 16201835 |
D000074 | Acenocoumarol | VKORC1 promoter polymorphism results in decreased susceptibility to Acenocoumarol | decreases response to substance | 19875892 |
D000074 | Acenocoumarol | VKORC1 protein polymorphism results in decreased susceptibility to Acenocoumarol | decreases response to substance | 17036862 |
D000082 | Acetaminophen | Acetaminophen affects the expression of VKORC1 mRNA | affects expression | 17562736 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of VKORC1 mRNA | decreases expression | 20106945 |
D003374 | Coumarins | Coumarins affects the activity of VKORC1 protein | affects activity | 18278162 |
C021636 | bromadiolone | VKORC1 gene mutant form results in decreased susceptibility to bromadiolone | decreases response to substance | 19752778 |
C004662 | chlorophacinone | VKORC1 gene mutant form results in decreased susceptibility to chlorophacinone | decreases response to substance | 19752778 |
D002995 | Clofibric Acid | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of VKORC1 mRNA | affects cotreatment|affects expression | 17602206 |
C030123 | coumarin | VKORC1 gene mutant form results in decreased susceptibility to coumarin | decreases response to substance | 18278162 |
C030123 | coumarin | VKORC1 gene mutant form results in increased susceptibility to coumarin | increases response to substance | 18278162 |
C030123 | coumarin | VKORC1 promoter SNP results in increased susceptibility to coumarin | increases response to substance | 17849045 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of VKORC1 mRNA | decreases expression | 20106945 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of VKORC1 mRNA | affects cotreatment|affects expression | 17602206 |
D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VKORC1 mRNA | affects cotreatment|increases expression | 17942748 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of VKORC1 mRNA | decreases expression | 17557909 |
D010644 | Phenprocoumon | VKORC1 gene polymorphism affects the susceptibility to Phenprocoumon | affects response to substance | 15536456 18698879 |
D010644 | Phenprocoumon | VKORC1 intron SNP affects the susceptibility to Phenprocoumon | affects response to substance | 16201835 |
D010644 | Phenprocoumon | VKORC1 protein polymorphism results in decreased susceptibility to Phenprocoumon | decreases response to substance | 17036862 |
D012643 | Selenium | [Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA | affects cotreatment|increases expression | 19244175 |
D012643 | Selenium | Selenium results in increased expression of VKORC1 mRNA | increases expression | 19244175 |
D018038 | Sodium Selenite | Sodium Selenite results in decreased expression of VKORC1 mRNA | decreases expression | 18175754 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VKORC1 mRNA | affects cotreatment|increases expression | 17942748 |
D014810 | Vitamin E | [Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA | affects cotreatment|increases expression | 19244175 |
D014810 | Vitamin E | Vitamin E results in increased expression of VKORC1 mRNA | increases expression | 19244175 |
D014859 | Warfarin | VKORC1 3' UTR results in decreased susceptibility to Warfarin | decreases response to substance | 16676068 |
D014859 | Warfarin | VKORC1 gene affects the susceptibility to Warfarin | affects response to substance | 19207028 15630486 |
D014859 | Warfarin | VKORC1 gene mutant form affects the susceptibility to Warfarin | affects response to substance | 16879214 |
D014859 | Warfarin | VKORC1 gene mutant form results in decreased susceptibility to Warfarin | decreases response to substance | 18266023 14765194 |
D014859 | Warfarin | VKORC1 gene polymorphism affects the susceptibility to Warfarin | affects response to substance | 19998810 19018718 18805772 18776969 18698879 16960144 16270629 15578879 15930419 16432637 16611750 16847429 16890578 17048007 17329985 17391071 17764537 18370846 18535201 18574025 19135231 19300499 19567378 20386359 20579077 |
D014859 | Warfarin | VKORC1 gene polymorphism results in decreased metabolism of Warfarin | decreases metabolic processing | 20073138 |
D014859 | Warfarin | VKORC1 gene polymorphism results in decreased susceptibility to Warfarin | decreases response to substance | 18030307 19942260 17961434 18034619 |
D014859 | Warfarin | VKORC1 intron polymorphism affects the susceptibility to Warfarin | affects response to substance | 18523153 15358623 |
D014859 | Warfarin | VKORC1 intron polymorphism results in increased susceptibility to Warfarin | increases response to substance | 16676068 |
D014859 | Warfarin | VKORC1 intron SNP affects the susceptibility to Warfarin | affects response to substance | 18240904 |
D014859 | Warfarin | VKORC1 promoter polymorphism affects the susceptibility to Warfarin | affects response to substance | 18523153 |
D014859 | Warfarin | VKORC1 protein affects the metabolism of Warfarin | affects metabolic processing | 20073138 |
D014859 | Warfarin | VKORC1 protein affects the susceptibility to Warfarin | affects response to substance | 19752777 |
D014859 | Warfarin | Warfarin results in decreased activity of VKORC1 protein | decreases activity | 19300499 18240904 14765194 18805772 |
D014859 | Warfarin | VKORC1 gene mutant form results in decreased susceptibility to Warfarin | decreases response to substance | 19200363 |
D014859 | Warfarin | VKORC1 gene mutant form results in decreased susceptibility to Warfarin | decreases response to substance | 15879509 |
D014859 | Warfarin | VKORC1 gene SNP affects the susceptibility to Warfarin | affects response to substance | 17009238 |
D014859 | Warfarin | VKORC1 protein SNP affects the metabolism of Warfarin | affects metabolic processing | 17009238 |
D014859 | Warfarin | VKORC1 gene mutant form results in decreased susceptibility to Warfarin | decreases response to substance | 14765194 16421894 15879509 19200363 |
D014859 | Warfarin | VKORC1 gene mutant form results in decreased susceptibility to Warfarin | decreases response to substance | 20497562 |
D014859 | Warfarin | VKORC1 gene polymorphism results in decreased susceptibility to Warfarin | decreases response to substance | 19884975 |
D014859 | Warfarin | VKORC1 protein affects the susceptibility to Warfarin | affects response to substance | 20497562 19884975 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 2.74 | 15322242 14514962 11752688 | |
MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 3.84 | 17505938 | |
MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 4.08 | 20464547 20127859 | |
MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 4.08 | 14692618 | |
MESH:D000236 | Adenoma | 4,4'-diaminodiphenylmethane | 10.76 | 3712494 | |
MESH:D000236 | Adenoma | Benzo(a)pyrene | 10.76 | 6695378 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 10.76 | 6695378 10737359 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 9.69 | 18056438 19052882 17162532 16434500 19061943 17620307 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 9.69 | 16835633 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.85 | 11748828 | |
MESH:D000799 | Angioedema | Acetaminophen | 3.74 | 10982225 | |
MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 3.96 | 19183758 | |
MESH:D001019 | Aortic Rupture | marker/mechanism | 16549638 | ||
MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 3.36 | 11256880 | |
MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 2.60 | 15885639 | |
MESH:D001321 | Autistic Disorder | Acetaminophen | 1.43 | 18445737 | |
MESH:D001660 | Biliary Tract Diseases | 4,4'-diaminodiphenylmethane | 4.91 | 11289319 1440618 | |
MESH:D001778 | Blood Coagulation Disorders | marker/mechanism | 19141161 | ||
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 2.94 | 12125929 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.69 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.69 | 15746008 | |
MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 1.80 | 20146248 17474063 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 1.80 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 1.80 | 20435547 | |
MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 3.82 | 16050911 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.71 | 16835633 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 8.67 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 8.67 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | 4,4'-diaminodiphenylmethane | 8.67 | 3581430 7296757 | |
MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 8.67 | 3084413 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 8.67 | 20084675 17055752 19335982 19208518 20007298 16935385 19539802 20512989 3581430 20214788 19519916 18788625 11831363 10672840 21159647 17173139 20524982 16288022 19822196 3084413 16807293 16569478 19701751 20514400 19394651 16698587 18393292 19052882 17428255 20727157 20935162 18494052 18785209 19919837 16779866 18210153 16878318 18506893 18978308 16328049 19418558 20432363 16830150 10737359 17761372 17978847 16502159 18971187 19383236 19107877 18056438 19171122 16681979 16540662 17162532 17138121 18665156 20101231 18691550 | |
MESH:D002292 | Carcinoma, Renal Cell | 4,4'-diaminodiphenylmethane | 2.62 | 7296757 | |
MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 2.02 | 20419170 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 2.31 | 18850075 16120746 18670907 | |
MESH:D002386 | Cataract | Acetaminophen | 2.52 | 10977129 | |
MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 15.38 | 6135515 | |
MESH:D002471 | Cell Transformation, Neoplastic | 4,4'-diaminodiphenylmethane | 15.38 | 7505956 | |
MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 15.38 | 12371664 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 15.38 | 17174075 2727394 21159647 7505956 | |
MESH:D002543 | Cerebral Hemorrhage | Warfarin | 5.74 | 11061249 | |
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 9.01 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 9.01 | 16835633 | |
MESH:D002779 | Cholestasis | 4,4'-diaminodiphenylmethane | 12.91 | 9022650 19486331 | |
MESH:D002779 | Cholestasis | Cyclosporine | 12.91 | 19486331 | |
MESH:D002779 | Cholestasis | Ethinyl Estradiol | 12.91 | 17333356 16919318 16105132 17110522 11677210 15861022 17681005 | |
MESH:D019457 | Chromosome Breakage | Sodium Selenite | 4.64 | 15894690 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 2.06 | 12621046 15340226 15668235 8697196 16354765 | |
MESH:D003092 | Colitis | Selenium | 3.67 | 17936198 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.96 | 14669216 17141729 | |
MESH:D003327 | Coronary Disease | marker/mechanism | 16549638 | ||
MESH:D023903 | Coronary Restenosis | Warfarin | 5.57 | 12872399 | |
OMIM:122700 | COUMARIN RESISTANCE | marker/mechanism | 20210733 20386359 20497562 20579077 14765194 | ||
OMIM:122700 | COUMARIN RESISTANCE | Warfarin | 5.72 | 20579077 20497562 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 2.45 | 20055451 15322242 10048152 | |
MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 2.45 | 19769572 | |
MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 10.53 | 18551238 | |
MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 10.53 | 18551238 | |
MESH:D017449 | Dermatitis, Allergic Contact | 4,4'-diaminodiphenylmethane | 2.70 | 8156756 11906362 8970840 12868966 18759878 14531868 2524372 11298694 | |
MESH:D003877 | Dermatitis, Contact | 4,4'-diaminodiphenylmethane | 3.39 | 3621924 2952479 | |
MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 3.68 | 16285004 | |
MESH:D003922 | Diabetes Mellitus, Type 1 | Warfarin | 4.02 | 18772604 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | coumarin | 7.04 | 19647726 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 7.04 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 7.04 | 17107852 | |
MESH:D003928 | Diabetic Nephropathies | Warfarin | 5.00 | 12644472 | |
MESH:D003875 | Drug Eruptions | Warfarin | 5.87 | 14723717 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 21.70 | 18551238 21346803 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 21.70 | 18551238 21346803 | |
MESH:D056486 | Drug-Induced Liver Injury | 4,4'-diaminodiphenylmethane | 21.70 | 9022650 18289764 6482804 18692083 18648102 7440962 8291058 16192314 11289319 1440618 6679447 9328219 9653073 | |
MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 21.70 | 16485898 12153990 16109766 17906064 11421492 10915739 19370779 16177239 12594235 19416960 11834606 12540782 16081117 19420014 14986274 11739529 2444490 16781746 12958197 14550746 16227642 10774834 17522070 11743745 17562736 18713872 16393943 10663392 19164858 11461765 19923254 12392966 15968718 19085960 11287661 12705907 19739265 11529661 15619225 14725611 18071297 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 21.70 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | Selenium | 21.70 | 15131321 | |
MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 21.70 | 15131321 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 21.70 | 20420201 | |
MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 3.99 | 19426721 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 2.68 | 11462148 | |
MESH:C538011 | Eales disease | Vitamin E | 4.60 | 9068938 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 2.28 | 12711302 11000095 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 3.80 | 16714409 15322242 18230668 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 3.08 | 12538720 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 2.92 | 9294722 10568697 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 5.01 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | 4,4'-diaminodiphenylmethane | 4.27 | 3581430 | |
MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 4.27 | 16530937 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 2.93 | 11564622 | |
MESH:D005234 | Fatty Liver | Cyclosporine | 12.47 | 19224547 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 12.47 | 20387270 21071580 | |
MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 12.47 | 15345470 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 3.35 | 11858732 | |
MESH:D005350 | Fibroma | 4,4'-diaminodiphenylmethane | 4.91 | 6705139 | |
MESH:D005355 | Fibrosis | Cyclosporine | 8.12 | 12168785 12639820 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 8.12 | 20067830 | |
MESH:D005756 | Gastritis | Acetaminophen | 3.57 | 16983495 | |
MESH:D006471 | Gastrointestinal Hemorrhage | Warfarin | 6.61 | 11794436 | |
MESH:D005776 | Gaucher Disease | Warfarin | 5.85 | 12359135 | |
MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 4.11 | 8708960 | |
MESH:D006042 | Goiter | 4,4'-diaminodiphenylmethane | 3.93 | 7505956 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.49 | 10696789 | |
MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 10.77 | 20471113 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 10.77 | 10048152 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Vitamin E | 10.77 | 16080930 | |
MESH:D006333 | Heart Failure | Selenium | 3.01 | 17162251 | |
MESH:D006406 | Hematoma | Warfarin | 6.61 | 17493413 | |
MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 4.31 | 15720958 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 10.17 | 11000095 | |
MESH:D006470 | Hemorrhage | Warfarin | 10.17 | 18429757 | |
MESH:D006505 | Hepatitis | 4,4'-diaminodiphenylmethane | 3.41 | 6705139 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 2.78 | 12621046 16120746 15340226 | |
MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 2.66 | 16490937 16863852 | |
MESH:D019584 | Hot Flashes | Vitamin E | 3.87 | 14716179 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.94 | 16354765 18606429 8697196 16959395 15340226 | |
MESH:D006930 | Hyperalgesia | Acetaminophen | 2.61 | 16870215 | |
MESH:D006965 | Hyperplasia | 4,4'-diaminodiphenylmethane | 3.83 | 15034207 | |
MESH:D006973 | Hypertension | Cyclosporine | 4.81 | 10903974 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 4.81 | 18850075 18670907 | |
MESH:D006976 | Hypertension, Pulmonary | Warfarin | 4.73 | 12359135 | |
MESH:D007021 | Hypospadias | Ethinyl Estradiol | 3.70 | 16569931 16945680 | |
MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 3.36 | 12013081 | |
MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 2.41 | 17937319 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 4.71 | 18785209 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 4.71 | 12878042 12200463 | |
MESH:D007251 | Influenza, Human | Selenium | 10.61 | 16624496 | |
MESH:D007251 | Influenza, Human | Vitamin E | 10.61 | 16624496 | |
MESH:D007333 | Insulin Resistance | Sodium Selenite | 3.20 | 14714311 | |
MESH:D007565 | Jaundice | 4,4'-diaminodiphenylmethane | 4.91 | 9022650 8074119 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 3.23 | 16580747 | |
MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 4.34 | 15604871 | |
MESH:D007674 | Kidney Diseases | Acetaminophen | 9.64 | 12587719 15629191 | |
MESH:D007674 | Kidney Diseases | Cyclosporine | 9.64 | 8314463 18776723 10903974 | |
MESH:D007674 | Kidney Diseases | Vitamin E | 9.64 | 12488133 | |
MESH:D007676 | Kidney Failure, Chronic | Selenium | 3.78 | 16518626 | |
MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 16.99 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 16.99 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | 4,4'-diaminodiphenylmethane | 16.99 | 6582329 | |
MESH:D007680 | Kidney Neoplasms | Cyclosporine | 16.99 | 12371664 | |
MESH:D054068 | Livedo Reticularis | Warfarin | 6.61 | 18280355 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 2.76 | 18665156 20032147 19638242 18407596 18522880 | |
MESH:D008105 | Liver Cirrhosis, Biliary | 4,4'-diaminodiphenylmethane | 3.13 | 9327722 15034207 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 2.31 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 2.31 | 16169303 | |
MESH:D008107 | Liver Diseases | Acetaminophen | 3.81 | 11587558 12969438 12587719 16611625 19460945 19014921 19784758 16610002 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 3.81 | 17034775 | |
MESH:D017114 | Liver Failure, Acute | Acetaminophen | 3.14 | 16871587 17185352 | |
MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 13.80 | 7678174 | |
MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 13.80 | 21137059 20195826 | |
MESH:D008113 | Liver Neoplasms | Clofibric Acid | 13.80 | 17602206 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 13.80 | 19254457 19427195 18644402 16942905 21167192 19073162 19294768 21047994 12771043 19256749 19090486 19833225 20137499 9163691 20583210 10737359 18977376 19690152 20434301 20405173 2862719 20492335 2422723 19426721 19996281 19642983 12112319 20452335 20501860 20101389 20118626 19638242 15885732 19499222 19812893 18754104 18648771 21278145 21071580 19850985 19551842 15175105 18978307 19255062 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 13.80 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 13.53 | 2876784 2876786 6135515 | |
MESH:D008114 | Liver Neoplasms, Experimental | 4,4'-diaminodiphenylmethane | 13.53 | 3712494 1399818 6587162 598648 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 13.53 | 3124819 18093689 18253720 2563599 18164116 17854601 17942915 17174075 19126423 19009564 18308698 19539802 18079962 18544905 21159647 19519916 19004024 16842330 9362446 18775883 16267830 18282651 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 13.53 | 12151625 | |
MESH:D008171 | Lung Diseases | Vitamin E | 3.10 | 16863852 | |
MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 4.72 | 20464547 20135361 17053015 20869020 18520028 20064080 6695378 18569708 18816296 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 4.72 | 20970405 6695378 21163286 20512841 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 4.72 | 19555203 11884234 | |
MESH:D008175 | Lung Neoplasms | Vitamin E | 4.72 | 11062179 | |
MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 3.95 | 14737004 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 2.69 | 15318939 | |
MESH:D008546 | Melanoma, Experimental | Acetaminophen | 3.46 | 19513568 | |
MESH:D008654 | Mesothelioma | Selenium | 2.75 | 15107826 | |
MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 4.68 | 16801185 | |
MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 3.10 | 16381670 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 2.93 | 12213967 | |
MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 17.27 | 18551238 | |
MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 17.27 | 18551238 7678174 | |
MESH:D009336 | Necrosis | Warfarin | 17.27 | 14723717 | |
MESH:D009362 | Neoplasm Metastasis | 4,4'-diaminodiphenylmethane | 5.56 | 3581430 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 5.56 | 3581430 9029167 | |
MESH:D009369 | Neoplasms | Benzo(a)pyrene | 2.12 | 11141357 | |
MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 4.34 | 17954296 | |
MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 3.19 | 19348381 18481113 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 3.11 | 14600291 | |
MESH:D009436 | Neural Tube Defects | 4,4'-diaminodiphenylmethane | 2.84 | 6679447 | |
MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 7.88 | 18514411 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 7.88 | 20387270 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 5.01 | 20387270 | |
MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 14.50 | 16049721 12819281 | |
MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 14.50 | 16049721 | |
MESH:D009784 | Occupational Diseases | 4,4'-diaminodiphenylmethane | 14.50 | 6482804 4026338 | |
MESH:D009902 | Optic Neuritis | 4,4'-diaminodiphenylmethane | 4.91 | 3988306 | |
MESH:D010146 | Pain | Acetaminophen | 2.30 | 16870215 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 2.38 | 16540662 | |
MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 3.58 | 11578682 | |
MESH:D010212 | Papilloma | 4,4'-diaminodiphenylmethane | 3.38 | 7296757 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 4.14 | 12520081 | |
MESH:D010787 | Photosensitivity Disorders | 4,4'-diaminodiphenylmethane | 4.36 | 6228378 | |
MESH:D010954 | Plasmacytoma | Selenium | 4.78 | 15087411 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.45 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Cyclosporine | 8.63 | 12371664 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 8.63 | 2563599 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 3.08 | 11222880 11118676 11399792 11896295 | |
MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 2.60 | 17292933 | |
MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 2.60 | 18760546 | |
MESH:D011471 | Prostatic Neoplasms | Vitamin E | 2.60 | 15084515 | |
MESH:D020151 | Protein C Deficiency | Warfarin | 6.24 | 18376272 | |
MESH:D011537 | Pruritus | Ethinyl Estradiol | 3.20 | 16919318 15861022 | |
MESH:D011565 | Psoriasis | Cyclosporine | 2.19 | 16882103 | |
MESH:D011655 | Pulmonary Embolism | Warfarin | 6.24 | 19300499 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.73 | 18990726 | |
MESH:D012162 | Retinal Degeneration | 4,4'-diaminodiphenylmethane | 3.29 | 3692021 | |
MESH:D012640 | Seizures | 2,4-dinitrotoluene | 5.62 | 18551238 | |
MESH:D012640 | Seizures | 2,6-dinitrotoluene | 5.62 | 18551238 | |
MESH:D012851 | Sinus Thrombosis, Intracranial | Warfarin | 5.76 | 12269725 | |
MESH:D012871 | Skin Diseases | Vitamin E | 2.41 | 18709164 | |
MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 5.30 | 10029692 19755658 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 5.30 | 16192470 | |
MESH:D013088 | Spermatocele | Ethinyl Estradiol | 3.84 | 16709447 | |
MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 2.30 | 2093021 20155912 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 2.30 | 18456281 | |
MESH:D020521 | Stroke | marker/mechanism | 16549638 | ||
MESH:D020521 | Stroke | Vitamin E | 8.84 | 16517955 | |
MESH:D020521 | Stroke | Warfarin | 8.84 | 19300499 | |
MESH:D013923 | Thromboembolism | Acenocoumarol | 22.60 | 18698879 | |
MESH:D013923 | Thromboembolism | Phenprocoumon | 22.60 | 18698879 | |
MESH:D013923 | Thromboembolism | Warfarin | 22.60 | 16960144 18698879 | |
MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 10.67 | 11994571 | |
MESH:D019851 | Thrombophilia | Warfarin | 10.67 | 17493413 | |
MESH:D013927 | Thrombosis | Ethinyl Estradiol | 9.10 | 15669648 | |
MESH:D013927 | Thrombosis | Warfarin | 9.10 | 17245631 11518727 11307788 17672075 19300499 15720958 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.80 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | 4,4'-diaminodiphenylmethane | 6.84 | 3712494 1399818 6587162 6582329 7505956 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 6.84 | 7505956 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 11.55 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 11.55 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | 4,4'-diaminodiphenylmethane | 11.55 | 8074119 | |
MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 11.55 | 17053015 | |
MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 11.63 | 10091137 | |
MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 11.63 | 10091137 | |
MESH:D014581 | Urticaria | Acetaminophen | 2.87 | 10982225 | |
MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 3.19 | 14692618 | |
MESH:D014605 | Uveitis | Cyclosporine | 3.88 | 1336536 | |
MESH:D014652 | Vascular Diseases | marker/mechanism | 16549638 | ||
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.49 | 12125929 | |
MESH:D014657 | Vasculitis | Warfarin | 5.76 | 20337814 | |
MESH:D014689 | Venous Insufficiency | coumarin | 5.67 | 12708602 | |
MESH:D054556 | Venous Thromboembolism | Warfarin | 6.26 | 18776969 | |
MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 10.40 | 14671159 15869587 | |
MESH:D020246 | Venous Thrombosis | Warfarin | 10.40 | 15733061 14723717 | |
OMIM:607473 | VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2 | marker/mechanism | 14765194 | ||
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 4.14 | 15886252 | |
MESH:D014985 | Xerophthalmia | Cyclosporine | 4.34 | 17120751 |
Pathway ID | Pathway Name |
---|---|
REACT:17015 | Metabolism of proteins |
Releated gene ID | Related gene Name |
---|---|
PA26047 | CALU |
PA133787052 | VKORC1 |
Releated disease ID | Related disease Name |
---|---|
PA445850 | Thrombosis |
PA443421 | Arrhythmias, Cardiac |
PA159018367 | Brugada syndrome |
PA443633 | Cardiomyopathy, Hypertrophic |
PA443796 | Coronary Artery Disease |
PA443797 | Coronary Disease |
PA446379 | Death, Sudden, Cardiac |
PA444807 | Long QT Syndrome |
PA445769 | Sudden Infant Death |
PA446294 | Torsades de Pointes |
PA446028 | Ventricular Fibrillation |
PA444368 | Heart Diseases |
PA445465 | Pulmonary Embolism |
PA447298 | venous thromboembolism |
PA446969 | Venous Thrombosis |
PA444417 | Hemorrhage |
PA446900 | Coagulation Protein Disorders |
PA446021 | Vascular Diseases |
PA443459 | Atrial Fibrillation |
PA443842 | Death |
PA443425 | Arteriosclerosis |
PA446997 | Intracranial Hemorrhages |
PA445019 | Myocardial Infarction |
PA153619833 | Peripheral Vascular Diseases |
PA447054 | Stroke |
PA445848 | Thromboembolism |
Releated drug ID | Related drug Name |
---|---|
PA448383 | amiodarone |
PA451363 | simvastatin |
PA164712547 | Beta blocking agents, selective |
PA451906 | warfarin |
PA134521193 | coumarin |
PA450921 | phenprocoumon |
PA452632 | acenocoumarol |
PA451906 | warfarin |
Drugbank ID | Action | Drug Name | Description |
---|---|---|---|
DB00170 | cofactor | Menadione | Dietary supplement;Micronutrient;Antifibrinolytic Agents;Vitamins/minerals;Vitamins |
DB00266 | antagonist | Dicumarol | Anticoagulants;Enzyme Inhibitors;Uncoupling Agents |
DB00498 | inhibitor | Phenindione | Anticoagulants |
DB00682 | antagonist | Warfarin | Anticoagulants;Rodenticides;Coumarin and Indandione Derivatives |
DB00946 | antagonist | Phenprocoumon | Anticoagulants |
DB01418 | antagonist | Acenocoumarol | Anticoagulants;Coumarin and Indandione Derivatives |
No data |
No data |
No data |